Loading...
Ongoing Phase I Studies of Immune Checkpoint Inhibitors in China
BACKGROUND. Cancer immunotherapy targeting immune checkpoint inhibitors (ICIs) has been shown to be a promising strategy in the treatment of various malignancies. Despite the proven efficacy and tolerability of ICIs based on 113 clinical trials globally, data regarding the pharmacokinetic (PK) and p...
Na minha lista:
| Udgivet i: | Oncologist |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley & Sons, Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6394776/ https://ncbi.nlm.nih.gov/pubmed/30819827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-IO-S1-s03 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|